During 2026:
- 3 more states (GA, ND, SC) removed prior authorization requirements.
- 2 states (ND, WV) removed substance use restrictions.
- 1 state (NV) removed prescriber restrictions.
- 3 states (GA, MD, ND) removed retreatment restrictions.
- 2 states (DC, UT) achieved MCO parity and transparency.
Overall Grades

A+ (24): Colorado, Connecticut, Delaware, District of Columbia, Idaho, Iowa, Kansas, Maine, Michigan, Missouri, New Hampshire, New Mexico, New York, North Carolina, North Dakota, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Texas, Virginia, Washington, Wisconsin
A (16): Alaska, Arizona, California, Florida, Georgia, Hawaii, Illinois, Indiana, Louisiana, Massachusetts, Minnesota, New Jersey, Puerto Rico, South Dakota, Tennessee, West Virginia
B (9): Alabama, Arkansas, Kentucky, Mississippi, Nevada, Ohio, Utah, Vermont, Wyoming
C (3): Maryland, Montana, Nebraska
Citation: Center for Health Law and Policy Innovation & National Viral Hepatitis Roundtable, Hepatitis C: State of Medicaid Access (2026), www.stateofhepc.org
Prior Authorization Requirements

No Prior Authorization for Most Patients (37): Alaska, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Louisiana, Maine, Massachusetts, Michigan, Minnesota, Missouri, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Texas, Virginia, Washington, West Virginia, Wisconsin
Prior Authorization Required (15): Alabama, Arkansas, Kentucky, Maryland, Mississippi, Montana, Nebraska, Nevada, Ohio, Puerto Rico, South Dakota, Tennessee, Utah, Vermont, Wyoming
Citation: Center for Health Law and Policy Innovation & National Viral Hepatitis Roundtable, Hepatitis C: State of Medicaid Access (2026), www.stateofhepc.org
Fibrosis Restrictions

No Fibrosis Restrictions (52): Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, DC, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming
Citation: Center for Health Law and Policy Innovation & National Viral Hepatitis Roundtable, Hepatitis C: State of Medicaid Access (2025), www.stateofhepc.org
Sobriety Restrictions

No Substance Use Restriction (48): Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming
Provider Must Address and/or Counsel Patient About Substance Use Issues Prior to Treatment (4): Alaska, Mississippi, Montana, Nebraska
Citation: Center for Health Law and Policy Innovation & National Viral Hepatitis Roundtable, Hepatitis C: State of Medicaid Access (2026), www.stateofhepc.org
Prescriber Restrictions

No Prescriber Restrictions for Simplified Treatment (50): Alabama, Alaska, Arizona, California, Colorado, Connecticut, DC, Delaware, Florida, Georgia, Hawaii, Idaho, Indiana, Iowa, Louisiana, Kansas, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming
Prescriber Restrictions (2): Arkansas, Illinois
Citation: Center for Health Law and Policy Innovation & National Viral Hepatitis Roundtable, Hepatitis C: State of Medicaid Access (2026), www.stateofhepc.org
Retreatment Restrictions

No Retreatment Restrictions (42): Alaska, Arkansas, Colorado, Connecticut, District of Columbia, Delaware, Georgia, Hawaii, Idaho, Illinois, Iowa, Kansas, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Vermont, Virginia, Washington, Wisconsin
Retreatment Restrictions based on adherence, substance use, or SVR12 documentation (10): Alabama, Arizona, California, Florida, Indiana, Kentucky, Montana, Utah, West Virginia, Wyoming
Citation: Center for Health Law and Policy Innovation & National Viral Hepatitis Roundtable, Hepatitis C: State of Medicaid Access (2026), www.stateofhepc.org
Managed Care Restrictions

No Additional Restrictions in Managed Care (36): Arkansas, Arizona, California, Colorado, Delaware, District of Columbia, Florida, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Mississippi, Missouri, New Hampshire, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, Tennessee, Texas, Utah, Virginia, Washington, West Virginia, Wisconsin
Additional Restrictions and/or Lack of Transparency in Managed Care (7): Georgia, Hawaii, Maryland, Minnesota, Nebraska, Nevada, New Jersey
N/A, State Doesn’t Contract with Managed Care (9): Alabama, Alaska, Connecticut, Idaho, Maine, Montana, South Dakota, Vermont, Wyoming
Citation: Center for Health Law and Policy Innovation & National Viral Hepatitis Roundtable, Hepatitis C: State of Medicaid Access (2026), www.stateofhepc.org
Compare this snapshot
with our previous updates: